“…There is not a standard medical treatment for pediatric AM, however empiric antimicrobial therapy should provide coverage for the principal pathogens: S. pnuemoniae[ 3 , 16 ], S. pyogenes and S. aureus (including methicillin resistant S. aureus in high prevalence areas). Therefore intravenous beta lactamase antibiotics are usually used as first line treatment, mostly as monotherapy [ 5 , 15 , 20 , 24 , 25 ], but also associated to amino glycosides [ 3 , 26 ], clindamycin [ 7 ], fosfomycin [ 27 ]. According to literature [ 5 ], we used parenteral Ceftriaxone considering the low prevalence of MRSA in our population.…”